Beta Drugs Ltd Share Price

Q: What is the share price of Beta Drugs Ltd today?

Beta Drugs Ltd share price as on 31 Jan 2025 is ₹1887.95

Pharmaceuticals - Indian - Bulk Drugs

NSE: BETA Small Cap ISIN: INE351Y01019

As on 31 January 2025 at 14:08 IST

₹1,887.95

-95.85

(-4.83%)

Sell Buy

Over 1 Month

-0.30%

Over 6 Months

51.24%

Over 1 Year

36.51%

Over 3 Years

219.45%

Beta Drugs Ltd Summary

Close ₹ 1,887.95

Open ₹ 1,980

High ₹ 1,980

Low ₹ 1,854.25

Volume 6,600

Net Turnover (in ₹ Cr) ₹ 0.63

52Wk High ₹ 2,326

52Wk Low ₹ 1,060.05

52Wk High / Low

1,060.05

2,326

Beta Drugs Ltd Fundamentals

Key Financial Data

Market Cap (in ₹Cr) ₹ 1,907.20

EPS (TTM) 22.82

Book Value (BV) 120.68

Div. Yield -

P/E (TTM) 86.93

Price/Book Value 16.44

Delivery % 59.38 %

Face Value 10

Key Ratios

PE Ratio 54.06

PB Ratio 10.22

EV to Sales 5.89

PEG Ratio 3.26

ROA 17.57

ROE 20.67

Debt-Equity 0.05

Net Profit Margin 11.10

Operating Profit Margin 17.84

Beta Drugs Ltd Financials

Profit and Loss

Consolidated

Standalone

Yearly

Quarterly

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	297.07	227.87	184.59	116.62	91.22
Total Expenses	248.32	186.81	150.29	100.67	79.24
Profit Before Tax	48.75	41.06	34.30	15.95	11.97
Profit After Tax	36.44	30.72	24.83	11.72	9.42
Operating Profit after Depreciation	51.57	43.47	36.20	18.37	14.56

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	64.59	62.76	54.95	39.97	43.82
Total Non Current Assets	76.23	70.74	60.89	49.46	51.14
Total Current Assets	177.87	127.68	96.96	68.04	56.04
TOTAL ASSETS	254.10	198.42	157.85	117.51	107.18
Total Shareholder's Fund	157.12	122.88	92.34	68.61	57.11

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	30.93	23.38	29.63	18.60	8.41
Net Cash used in Investing Activities	-13.97	-19.07	-21.75	-5.85	-15.05
Net Cash used in Financing Activities	-7.49	-2.47	-0.97	-7.71	8.73

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	199.35	158.92	125.70	80.07	65.74
Total Expenses	169.87	133.71	105.54	70.19	56.79
Profit Before Tax	29.48	25.21	20.16	9.88	8.95
Profit After Tax	21.94	18.82	14.25	6.98	7.10
Operating Profit after Depreciation	30.53	26.05	20.57	10.65	9.59

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	36.48	34.77	34.06	28.01	31.67
Total Non Current Assets	56.80	49.04	48.14	42.68	45.05
Total Current Assets	113.67	85	62.76	43.55	37.17
TOTAL ASSETS	170.47	134.04	110.90	86.23	82.21
Total Shareholder's Fund	116.01	96.26	77.46	63.42	56.44

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	21.19	10.23	18.76	11.60	6.09
Net Cash used in Investing Activities	-11.02	-5.82	-12.72	-3.15	-14.33
Net Cash used in Financing Activities	-0.76	-2.19	1.27	-4.34	9.48

No data available

Beta Drugs Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 1,951.22

S2 1,918.63

S3 1,897.27

Pivot 1,972.58

R1 2,005.17

R2 2,026.53

R3 2,059.12

Moving Average

20 SMA 1,915.35

50 SMA 2,040.64

100 SMA 1,934.05

200 SMA 1,623.95

Beta Drugs Ltd Corporate Actions

Dividend

Bonus

Splits

Rights

AGM

EGM

No available data

AGM Date: 29 Sep 2022

Beta Drugs Limited has informed the Exchange about Notice of Annual General Meeting to be held on 29-Sep-2022 Beta Drugs Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 22-Sep-2022 to 29-Sep-2022 for the purpose of Meeting. Beta Drugs Limited has informed the Exchange about Notice of Annual General Meeting to be held on 29-Sep-2022 (As Per NSE Announcement Dated on 05.09.2022) Beta Drugs Limited has informed the Exchange about Newspaper Advertisements (As Per NSE Announcement Dated on 06.09.2022) Beta Drugs Limited has informed the Exchange about Proceedings of Annual General Meeting held on 29-Sep-2022 (As Per NSE Announcement Dated on 29.09.2022) Beta Drugs Limited has informed the Exchange about Voting results of Annual General Meeting held on 29-Sep-2022 Beta Drugs Limited has informed the Exchange about Voting results and Scrutinizer report of Annual General Meeting held on 29-Sep-2022 (As Per NSE Announcement Dated on 01.10.2022) Beta Drugs Limited has informed the Exchange about Minutes of Annual General Meeting held on 29-Sep-2022 (As Per NSE Announcement Dated on 04.10.2022)

AGM Date: 30 Sep 2023

Beta Drugs Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2023 Beta Drugs Limited has informed the Exchange with copy of minutes of Annual General Meeting held on September 30, 2023 (As Per NSE Announcement Dated on 04/10/2023)

AGM Date: 30 Sep 2024

Beta Drugs Limited has informed the Exchange regarding Board meeting held on August 31, 2024. Beta Drugs Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2024 (As Per NSE Announcement Dated on: 30/09/2024) Beta Drugs Limited has informed the Exchange regarding voting results of Annual General Meeting held on September 30, 2024 (As Per NSE Announcement Dated on: 01/10/2024)

Beta Drugs Ltd Peer Comparison

Company	Price	Market Cap (in ₹ Cr)
Beta Drugs Ltd	₹1,983.80	₹1,907.20
Sun Pharmaceuticals Industries Ltd	₹1,745.25	₹4,18,743.94
Divis Laboratories Ltd	₹5,733.60	₹1,52,209.07
Cipla Ltd	₹1,458.15	₹1,17,762.24
Torrent Pharmaceuticals Ltd	₹3,357.15	₹1,13,616.11
Mankind Pharma Ltd	₹2,488.40	₹1,02,663.15

Beta Drugs Ltd News

Beta Drugs schedules EGM

On 21 December 2024

28 Nov 2024, 03:41 pm

Beta Drugs to conduct board meeting

On 6 November 2024

04 Nov 2024, 02:01 pm

Beta Drugs to conduct EGM

On 12 November 2024

21 Oct 2024, 01:59 pm

Beta Drugs schedules AGM

On 30 September 2024

02 Sep 2024, 05:17 pm

Beta Drugs to discuss results

On 14 May 2024

07 May 2024, 12:58 pm

Beta Drugs Ltd Stock Analysis

Annual revenue for Beta Drugs Ltd increased by 25.44% to ₹199.35 crore in FY 2024 from ₹158.92 crore in FY 2023.
Annual Net Profit for Beta Drugs Ltd increased by 16.58% to ₹21.94 crore in FY 2024 from ₹18.82 crore in FY 2023.
Promoter Shareholding in Beta Drugs Ltd remains unchanged by 0.00% in the most recent quarter, from 66.73% in November 2024 to 66.73% in December 2024.
Beta Drugs Ltd delivered a 1-year return of 36.51% compared to the Nifty 50, which provided a return of 8.03% as of the last trading session.
Beta Drugs Ltd share price moved down by 4.83% from its previous close of INR ₹1,983.80. The latest Beta Drugs Ltd share price is INR ₹1,887.95.
Beta Drugs Ltd share price today has been at a low of 1,854.25 and a high of 1,980. Over the past 52 weeks, the Beta Drugs Ltd share price has seen a low of 1,060.05 and a high of 2,326.